Projects per year
Personal profile
Fingerprint
Dive into the research topics where Andreas Reinisch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
AML PDX: Developing a Leukemia Patient-Derived Xenotransplantation Repository for Predicting AML Treatment Response and Relapse
Reinisch, A. (Principal investigator)
1/03/25 → 28/02/27
Project: Research funding
-
Aberrant immune signaling and clonal dominance in splicing factor mutant myeloid malignancies
Reinisch, A. (Principal investigator)
1/04/24 → 31/12/27
Project: Research funding
-
Identification of leukemic niche interactions in acute myeloid leukemia
Reinisch, A. (Principal investigator)
1/07/20 → 30/12/26
Project: Research funding
-
Engineering spliceosome mutati: Aberrant innate immune signaling in spliceosome-mutant myeloid neoplasms
Reinisch, A. (Principal investigator)
1/02/24 → 31/01/26
Project: Research funding
-
JAK2 gene dosage: Investigating the effect of JAK2V617F gene dosage on MPN phenotype by forward and reverse CRISPR/Cas9 genome engineering.
Reinisch, A. (Principal investigator)
1/01/22 → 31/12/24
Project: Research funding
-
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib Sensitivity.
Thompson-Peach, C., Thomas, D., Dottore, M., Lim, K., Stomski, F., Panagopoulos, R., Foßelteder, J., Reinisch, A., Chandrakanthan, V., Jenkner, S., Bland, L., Paton, S., Gronthos, S., Hercus, T., Wardill, H., Kan, W., Kamel, M., Moretti, P., Pitson, S. & Burbury, K. & 4 others, , 2 Apr 2026, In: Blood. 147, 14, p. 1611-1623 13 p.Research output: Contribution to journal › Research article
2 Citations (Web of Science) -
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care center.
Wurm, S. (First author), Waltersdorfer, M., Loindl, S., Neiss, J. M., Herzog, S. A., Bachmaier, G., Berghold, A., Kashofer, K., Beham-Schmid, C., Höfler, G., Greinix, H., Wölfler, A., Reinisch, A., Sill, H. & Zebisch, A. (Last author), Aug 2025, In: Wiener Klinische Wochenschrift. 137, 15-16, p. 504-516 13 p.Research output: Contribution to journal › Research article
6 Citations (Web of Science) -
Correction to: Pulmonary Coinfection of <i>Pneumocystis jirovecii</i> and <i>Aspergillus</i> Species
Hatzl, S., Geiger, C., Kriegl, L., Reinisch, A., Woelfler, A., Apfaltrer, G., Keldorfer, M., Roedl, S., Hoenigl, M., Eller, P. & Krause, R., 17 Feb 2025, In: Open Forum Infectious Diseases. 12, 2, p. ofaf083 1 p., ofaf083.Research output: Contribution to journal › Communication
-
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.
Wurm, S. (First author), Neiss, J. M., Petzer, V., Wolf, D., Gleixner, K., Sperr, W., Groiss, C., Machherndl-Spandl, S., Eisenwort, G., Koller, E., Schoeche, J., Petrasch, C., Singer, J., Mayer, D., Pregartner, G., Heine, A., Wölfler, A., Sill, H., Reinisch, A. & Zebisch, A., 22 Oct 2025, In: Blood Cancer Journal. 15, 1, p. 175 5 p., 175.Research output: Contribution to journal › Research letter
3 Citations (Web of Science) -
Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.
Foßelteder, J. (First author), Brauchart, T., Schlacher, A., Sconocchia, T., Özkaya, E., Auinger, L., Schlenke, P., Sill, H., Zebisch, A. & Reinisch, A. (Last author), Jul 2025, In: Experimental Hematology. 147, p. 104790 7 p., 104790.Research output: Contribution to journal › Research article
1 Citation (Web of Science)
-
Dysplastic leukocyte features as detected by flow cytometry predict overall survival in patients with myelofibrosis
Kleinrath, C. (Speaker), Zaininger, P. (Author), Gruber, S. (Author), Hemetsberger, L. (Author), Richtig, G. (Author), Neiss, J. M. (Author), Wurm, S. (Author), Heine, A. (Author), Zebisch, A. (Author), Reinisch, A. (Author) & Wölfler, A. (Author)
2026Activity: Talk, presentation or poster › Poster
-
CRISPR/CAS9 genome engineering to model TET2 mutant myeloid effector cells and its pro-atherogenic potential.
Auinger, L. (Author) & Reinisch, A. (Author)
2025Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Blood (Journal)
Reinisch, A. (Reviewer)
2025Activity: Peer-review and editorial work › Peer-review activitiy
-
Nature Communications (Journal)
Reinisch, A. (Reviewer)
2024Activity: Peer-review and editorial work › Peer-review activitiy
-
Modeling SRSF2/TET2 mutational cooperativity in CMML development
Reinisch, A. (Author)
2024Activity: Talk, presentation or poster › Poster
Prizes
Thesis
-
Towards a better understanding of non-hematopoietic stem and progenitor biology and function
Reinisch, A. (Author), Dohr, G. (Supervisor), Linkesch, W. (Supervisor) & Strunk, D. (Supervisor), 2016Student thesis: Doctoral thesis